MASECO Private Wealth’s Pfizer PFE Stock Holding History

MASECO Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$175K	Sell	7,281 -21	-0.3%	-$549	﹤0.01%	118
2026 Q1	$205K	Sell	7,302 -206	-3%	-$5.48K	0.01%	106
2025 Q4	$187K	Buy	+7,508	New	+$189K	0.01%	96
2025 Q3	–	Sell	-9,571	Closed	-$232K	–	443
2025 Q2	$232K	Buy	+9,571	New	+$223K	0.01%	99

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MASECO Private Wealth's PFE Position: Q2 2026 in Review

MASECO Private Wealth reduced its Pfizer (PFE) stake by 0.29% in Q2 2026, selling an estimated $549 and leaving 7,281 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #118.

MASECO Private Wealth first reported a position in PFE in Q2 2025 and has held it in 4 quarters since. The position peaked at $232K in Q2 2025. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

MASECO Private Wealth held 7,281 shares of Pfizer worth $175K as of Q2 2026.
MASECO Private Wealth sold 21 Pfizer shares in Q2 2026, an estimated $549.
Pfizer made up ﹤0.01% of MASECO Private Wealth's portfolio in Q2 2026, its #118 holding.
MASECO Private Wealth first reported a position in Pfizer in Q2 2025 and has held it in 4 quarters since.
MASECO Private Wealth's Pfizer position peaked at $232K in Q2 2025.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MASECO Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.